3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Pleural Effusion, Malignant
2
Mesothelioma, Malignant
2
Breast Neoplasms
2
Recurrence
1
Rare Malignant Neoplasm
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Melanoma
1
Lymphoma
1
Lymphedema
1
Immunoglobulin Light-chain Amyloidosis
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Gynecological Cancers
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Dysplastic Nevus Syndrome
1
Complicated Adrenal Tumor Diseases
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
BRAF V600 Colorectal Cancer
1
Anxiety Disorders
1
Interventions
trametinib
1
dabrafenib
1
Surgical Procedures, Operative
1
Pharmaceutical Preparations
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Rare Malignant Neoplasm
×
Pharmaceutical Preparations
×
Clear all
NCT06872853
2025-03-12
RAC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Recruiting
1,100 enrolled